-
UTI Healthcare IDCW-R
Equity healthcare
Overview ( as on 05/12/25 )
NAV
₹222.58
Last change
₹-1.06 -0.0%
Fund Size (AUM)
1124.88 Cr
Performance
16.0% (5Y)
Fund Details
UTI Healthcare IDCW-R
as of 05/12/25
AUM
1124.88 Cr
Expense Ratio
2.26 %
Benchmark
BSE Healthcare TR INR
ISIN
INF789F01687
Fund Manager
Kamal Gada
Exit Load
1.0% if redeemed within 0-30 days
0% if redeemed after 30 days
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| UTI Healthcare IDCW-R | -1.2% | 23.48% | 16.0% |
| BSE Healthcare TR INR | 2.79% | 23.3% | 17.18% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
9.76% |
Ajanta Pharma Ltd |
6.48% |
Lupin Ltd |
5.91% |
Glenmark Pharmaceuticals Ltd |
4.06% |
Dr Reddy's Laboratories Ltd |
3.74% |
Gland Pharma Ltd |
3.46% |
Apollo Hospitals Enterprise Ltd |
3.45% |
Alkem Laboratories Ltd |
3.43% |
Procter & Gamble Health Ltd |
3.41% |
Cipla Ltd |
3.4% |
Sector Allocation
Healthcare |
98.95% |
Basic Materials |
1.05% |
Asset Allocation
-
99%
Equity
-
1%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Growth
Equity healthcare-
Returns
-
18.62% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
17.95% (5Y)
-
-
UTI Healthcare Growth
Equity healthcare-
Returns
-
16.0% (5Y)
-
-
UTI Healthcare IDCW-P
Equity healthcare-
Returns
-
16.0% (5Y)
-
-
UTI Healthcare IDCW-R
Equity healthcare-
Returns
-
16.0% (5Y)
-
-
SBI Healthcare Opportunities Growth
Equity healthcare-
Returns
-
17.72% (5Y)
-
